RegMed Daily, Closing Bell, 2/8/12, rebound theory, sell-off to positive to sell-off again to slightly positive
EOD Commentary: Stocks struggled to turn higher in a choppy session Wednesday, as investors continued to wait to see if the euro zone political leaders would come up with a resolution to the Greek sovereign debt crisis.
Closing Bell: The NASDAQ closed UP +11.78 (+0.4%) to 2,859.68. The Dow closed UP +5.75 (+0.04%) to 12,883.95.
Who’s up … at the close:
- Biomimetic (BMTI) +$0.05 <+2.23%> to $2.29;
- BioTime (Amex: BTX) +$0.23 <+4.01%> to $5.97;
- Fibrocell (OTC BB:FCSC) +$0.01 <+2.63%> to $0.39;
- Geron (GERN) +$o.08 <+ 4.02%> to $2.07;
- Opexa (OPXA) +$0.065 <+6.99%> to $0.995;
- Pluristem (PSTI) +$0.04 <+1.54%> to $2.63;
- StemCells (STEM) +$0.01 <+0.97%> to $1.04;
- Thermogenesis (KOOl) +$0.02 >+1.57%> to $1.15;
- Verstem (VSTM) +$0.07 <+0.64%> to $11.00.
- ThermoGenesis (KOOL) +$0.02 <+1.57%> to $1.15.
Categories: RegMed Daily Closing Bell
![50194787B[1]](http://www.scimitarequity.com/blog/wp-content/uploads/50194787B1-e1307466532356.jpg)







